Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 5 Relationship of lymph node metastasis with overall survival according to tumor types

From: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy outcomes in peritoneal carcinomatosis: 11-year tertiary-center experience

  

Lymph Node Metastasis

Absent

 

Present

 

Tumor site

N

Median (%95 CI)

N

Median (%95 CI)

P-value

Appendiceal

12

115 (42-NR)

6

8.3 (2.7–17.8)

0.006*

Peritoneal

11

20,8 (11,6–38,9)

2

10 (9,2–12,7)

0.217

Colorectal

8

27,3 (16.8–37.4)

30

11,8 (5.4–20.9)

0.045*

Gastric

2

7,6 (2,5–13,7)

18

9,4 (6,1–25,8)

0.482

  1. *p < 0.05, Log Rank test, CC: Completeness of cytoreduction, CI: Confidence interval, NR: Not reached
  2. All p-values less than 0.05 was bold
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us